Abstract
The key role of carbohydrates in nutrition is to deliver energy to the body. Until recently, debates on preferred types of carbohydrates as opposed to those that should be avoided focused mainly on a simple food chemistry approach. This approach does not reflect physiology, although it is used for food labelling and analysis purposes. It is the metabolism of carbohydrates that counts when we consider the increasing burden of non-communicable diseases. Since carbohydrates are the largest macronutrient category, with a recommended intake of 55%–75%, their influence is significant. Digestibility, availability, speed of absorption and metabolic pathways are key. It is the quality of carbohydrates that matters and a low glycaemic diet that counts. Tasty, lower glycaemic food can be achieved in various ways. Reducing the blood glucose response of available carbohydrates by modification of the glucose supply can be achieved by processing, by influencing the gastrointestinal passage and by a smart choice of ingredients: by selecting low glycaemic and slow-release carbohydrates. An alternative route is the replacement of available carbohydrates by partially or non-available carbohydrates, such as dietary fibre or traditional sugar replacers.
Article PDF
Similar content being viewed by others
References
European Food Safety Authority (2010) EFSA sets European dietary reference values for nutrient intakes. News story 26 March. http://www.efsa.europa.eu/en/press/news/nda100326.htm. Accessed 19 November 2013
WHO/FAO (2003) Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series 916. WHO/FAO, Geneva
Siddiqui IR, Furgala B (1967) Isolation and characterization of oligosaccharides from honey. Part 1. J Apic Res 6(3):139–149
Eggleston G, Grisham M (2003) Oligosaccharides in cane and their formation on cane deterioration. In: Eggleston G, Cote G (eds) Oligosaccharides in food and agriculture. ACS Symposium Series. ACS, Washington, DC, pp 211–232
Irwin WE, Sträter PJ (2001) Isomaltulose. In: O’Brien-Nabors L (ed.) Alternative sweeteners, 3rd edn. Marcel Dekker, New York, pp 413–421
Sentko A, Bernard J (2012) Isomaltulose. In: O’Brien-Nabors L (ed.) Alternative sweeteners, 4th edn. Taylor & Francis, Boca Raton, FL, pp 423–438
Holub I, Gostner A, Theis S, Nosek L, Kudlich T, Melcher R et al (2010) Novel findings on the metabolic effects of the low glycaemic carbohydrate isomaltulose (Palatinose). Br J Nutr 103(12):1730–1737
van Can JG, Ijzerman TH, van Loon LJ, Brouns F, Blaak EE (2009) Reduced glycaemic and insulinaemic responses following isomaltulose ingestion: implications for postprandial substrate use. Br J Nutr 102(10):1408–1413
König D, Theis S, Kozianowski G, Berg A (2012) Postprandial substrate use in overweight subjects with the metabolic syndrome after isomaltulose (Palatinose) ingestion. Nutrition 28(6):651–656
Kawai K, Yoshikawa H, Murayama Y, Okuda Y, Yamashita K (1989) Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm Metab Res 21(6):338–340
Liao ZH, Li YB, Yao B, Fan HD, Hu G, Weng JP (2001) The effects of isomaltulose on blood glucose and lipids for diabetic subjects. Acta Nutrimenta Sinica 23(4):373–375
West DJ, Morton RD, Stephens JW, Bain SC, Kilduff LP, Luzio S et al (2011) Isomaltulose improves postexercise glycemia by reducing CHO oxidation in T1DM. Med Sci Sports Exerc 43(2):204–210
Bracken RM, Page R, Gray B, Kilduff LP, West DJ, Stephens JW et al (2012) Isomaltulose improves glycemia and maintains run performance in type 1 diabetes. Med Sci Sports Exerc 44(5):800–808
Arai H, Mizuno A, Sakuma M, Fukaya M, Matsuo K, Muto K et al (2007) Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy men. Metabolism 56(1):115–121
Sato K, Arai H, Miyazawa Y, Fukaya M, Uebanso T, Koganei M et al (2008) Palatinose and oleic acid act together to prevent pancreatic islet disruption in nondiabetic obese Zucker rats. J Med Invest 55(3–4):183–195
Arai H, Mizuno A, Matsuo K, Fukaya M, Sasaki H, Arima H et al (2004) Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism 53(8):977–983
Fujiwara T, Naomoto Y, Motoki T, Shigemitsu K, Shirakawa Y, Yamatsuji T et al (2007) Effects of a novel palatinose based enteral formula (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes mellitus. J Surg Res 138(2):231–240
Yamori Y, Mori H, Mori M, Kashimura J, Sakamua T, Ishikawa PM et al (2007) Japanese perspective on reduction in lifestyle disease risk in immigrant Japanese Brazilians: a double-blind, placebo-controlled intervention study on palatinose. Clin Exp Pharmacol Physiol 34:S5–S7
Okuno M, Kim MK, Mizu M, Mori M, Mori H, Yamori Y (2010) Palatinose-blended sugar compared with sucrose: different effects on insulin sensitivity after 12 weeks supplementation in sedentary adults. Int J Food Sci Nutr 61(6):643–651
Oizumi T, Daimon M, Jimbu Y, Kameda W, Arawaka N, Yamaguchi H et al (2007) A palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat composition. Tohoku J Exp Med 212(2):91–99
Sakuma M, Arai H, Mizuno A, Fukaya M, Matsuura M, Sasaki H et al (2009) Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by longterm administration of a palatinose-based liquid formula as a part of breakfast. J Clin Biochem Nutr 45(2):155–162
Brunner S, Holub I, Theis S, Gostner A, Melcher R, Wolf P et al (2012) Metabolic effects of replacing sucrose by isomaltulose in subjects with type 2 diabetes: a randomized double-blind trial. Diabetes Care 35(6):1249–1251
Sydney University. http://www.glycemicindex.com/food-Search.php. Accessed 17 November 2013
Livesey G (2003) Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 16:163–191
Holub I, Gostner A, Hessdorfer S, Theis S, Bender G, Willinger B et al (2009) Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus. Horm Metab Res 41(12):886–892
Meyer D (2007) Inulin for product development of low GI products to support weight management. In: Salovaara H, Gates F, Tenkanen M (eds) Dietary fibre components and functions. Academic, Wageningen, pp 257–269
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sentko, A. Innovative low-glycaemic carbohydrates: an update. Nutrafoods 12, 127–135 (2013). https://doi.org/10.1007/s13749-013-0062-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13749-013-0062-2